Merck

Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc has priced its oral antiviral drug…

This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options

Series would be routinely recommended both for adults 65 years and older and for adults aged 19 to 64 at an increased risk for…

The money will support efforts to develop and make generic versions of what could become the first oral antiviral medication for…

Merck's experimental pill Molnupiravir is likely to be one of the drugs, and other drugs to treat mild patients are being…

The US FDA's panel will meet on 30th November, 2021 to discuss the safety and effectiveness of Molnupiravir for the treatment of…

The clinical collaboration builds on the success of a strategic research collaboration agreement between the two companies…

VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…

The aid is being utilised for procuring equipment of 250 oxygen concentrators, 100 ventilator units, and setting up oxygen…

Collaboration to focus on oral and injectable formulations of Lenacapavir and Islatravir